Mengxi Du1,2, Selena H Liu2, Cara Mitchell2, Teresa T Fung2,3. 1. Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA. 2. Department of Nutrition, Simmons College, Boston, MA. 3. Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA.
Abstract
Background: Estrogen receptor-negative (ER-) breast cancer tends to have poorer prognosis than estrogen receptor-positive breast cancer. A number of studies have examined the association between diet quality as measured by various diet quality scores and the risk of ER- breast cancer. Objective: This systematic review aimed to summarize existing evidence on this topic. Methods: Medline and Embase searches were conducted until 2 April 2017 for cohort and case-control studies on diet quality scores and ER- breast cancer. Results: We included 6 prospective cohort studies and 1 case-control study on postmenopausal ER- breast cancer: 4 from Europe and 3 from the United States. There were 12 different diet quality scores: 2 versions of the Dietary Inflammatory Index, 4 versions of the Mediterranean diet score, the Healthy Eating Index, the Alternate Healthy Eating Index, the Dietary Approaches to Stop Hypertension (DASH) score, and 3 versions of low-carbohydrate diet scores that differentiate between different sources of protein and fat. Of the 4 studies on Mediterranean diet scores, 3 showed a significant inverse association with postmenopausal ER- breast cancer, whereas no consistent association was observed with the other diet quality scores. Although most diet quality scores in this review share similar food components, most of the non-Mediterranean diet scores were represented by only 1 study each, and the associations with postmenopausal ER- breast cancer were mixed. All studies were adjusted for multiple covariates. Conclusion: This systematic review shows mixed results for an association between a variety of diet quality scores and postmenopausal ER- cancer. However, results from different versions of the Mediterranean diet scores are more consistent and suggest an inverse relation with ER- breast cancer.
Background: Estrogen receptor-negative (ER-) breast cancer tends to have poorer prognosis than estrogen receptor-positive breast cancer. A number of studies have examined the association between diet quality as measured by various diet quality scores and the risk of ER- breast cancer. Objective: This systematic review aimed to summarize existing evidence on this topic. Methods: Medline and Embase searches were conducted until 2 April 2017 for cohort and case-control studies on diet quality scores and ER- breast cancer. Results: We included 6 prospective cohort studies and 1 case-control study on postmenopausal ER- breast cancer: 4 from Europe and 3 from the United States. There were 12 different diet quality scores: 2 versions of the Dietary Inflammatory Index, 4 versions of the Mediterranean diet score, the Healthy Eating Index, the Alternate Healthy Eating Index, the Dietary Approaches to Stop Hypertension (DASH) score, and 3 versions of low-carbohydrate diet scores that differentiate between different sources of protein and fat. Of the 4 studies on Mediterranean diet scores, 3 showed a significant inverse association with postmenopausal ER- breast cancer, whereas no consistent association was observed with the other diet quality scores. Although most diet quality scores in this review share similar food components, most of the non-Mediterranean diet scores were represented by only 1 study each, and the associations with postmenopausal ER- breast cancer were mixed. All studies were adjusted for multiple covariates. Conclusion: This systematic review shows mixed results for an association between a variety of diet quality scores and postmenopausal ER- cancer. However, results from different versions of the Mediterranean diet scores are more consistent and suggest an inverse relation with ER- breast cancer.
Authors: Nicholas J Marchello; Heather D Gibbs; Debra K Sullivan; Mathew K Taylor; Jill M Hamilton-Reeves; Alvin F Beltramo; Christie A Befort Journal: J Cancer Surviv Date: 2020-10-15 Impact factor: 4.442
Authors: Yong-Moon Mark Park; Nitin Shivappa; Joshua Petimar; M Elizabeth Hodgson; Hazel B Nichols; Susan E Steck; James R Hébert; Dale P Sandler Journal: Int J Cancer Date: 2021-04-27 Impact factor: 7.316
Authors: Maryam Kazemi; Brittany Y Jarrett; Heidi Vanden Brink; Annie W Lin; Kathleen M Hoeger; Steven D Spandorfer; Marla E Lujan Journal: Nutrients Date: 2020-06-30 Impact factor: 5.717
Authors: Andrea Romanos-Nanclares; Walter C Willett; Bernard A Rosner; Laura C Collins; Frank B Hu; Estefania Toledo; A Heather Eliassen Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-07-21 Impact factor: 4.254